Crystal form of reduced coenzyme Q10 and preparation method therefor
AssigneeXinkailian Biotechnology (Hainan) Co., Ltd
InventorsLun Li, Niangen Chen, Gen Li
Life of this patent
Estimating the term…
Abstract
A crystal form of reduced coenzyme Q10 is provided. A method for preparing the crystal form of reduced coenzyme Q10 is provided. In addition, a crystalline solid of reduced coenzyme Q10 comprising the crystal form and a reduced coenzyme Q10 composition comprising the crystal form of reduced coenzyme Q10 are also provided.
Claims3
A method for preparing a crystal form of reduced coenzyme Q10, wherein the crystal form of reduced coenzyme Q10 has an endothermic peak at 52±2° C. in a differential scanning calorimetry trace with a heating rate of 10 k/min, and has an X-ray powder diffraction pattern as shown in FIG. 1;
- and
- the method comprises:
- mixing and dissolving reduced coenzyme Q10 with a cyclic ether solvent under heating, adding a mixed solution of a fluorine-containing alcohol solvent and an organic base, and performing crystallization by cooling to obtain a crystal form of reduced coenzyme Q10;
- wherein the crystallization is performed at a temperature of 0° C. to 20° C.;
- the reduced coenzyme Q10 and the cyclic ether solvent are in a ratio of 1 g:(2-10) mL;
- the cyclic ether solvent and the fluorine-containing alcohol solvent are in a volume ratio of 1:(1-5);
- and
- the organic base is 5% to 10% by mass of the reduced coenzyme Q10;
- wherein the cyclic ether solvent is selected from the group consisting of 2-methyltetrahydrofuran, tetrahydrofuran, and a combination thereof;
- the fluorine-containing alcohol solvent is selected from the group consisting of trifluoromethanol, trifluoroethanol, trifluoropropanol, trifluorobutanol and a combination thereof;
- and
- the organic base is triethylamine.
Dependencies are inferred from the claim text.